Cargando…
Identifying Epidermolysis Bullosa Patient Needs and Perceived Treatment Benefits: An Explorative Study Using the Patient Benefit Index
Epidermolysis bullosa (EB) is a genetic blistering skin condition for which no cure exists. Symptom alleviation and quality of life are therefore central to EB care. This study aimed to gain insight into EB patient needs and benefits from current clinical care. Two questionnaires were administered c...
Autores principales: | Schräder, Nicholas H. B., Korte, Eva W. H., Duipmans, José C., Stewart, Roy E., Bolling, Maria C., Wolff, André P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709493/ https://www.ncbi.nlm.nih.gov/pubmed/34945131 http://dx.doi.org/10.3390/jcm10245836 |
Ejemplares similares
-
Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study
por: Schräder, Nicholas H. B., et al.
Publicado: (2021) -
Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three cases
por: Schräder, N.H.B., et al.
Publicado: (2018) -
Patients’ and parents’ experiences during wound care of epidermolysis bullosa from a dyadic perspective: a survey study
por: Mauritz, Petra J., et al.
Publicado: (2022) -
The C4EB study—Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study
por: Schräder, Nicholas H. B., et al.
Publicado: (2022) -
The importance of accurate epidemiological data of epidermolysis bullosa
por: Baardman, Rosalie, et al.
Publicado: (2022)